Allergy Therapeutics (AGY.LSE) Q1 2025 Earnings

31MarConfirmed
Q1 2024
Q1 2024
Q4 2024
Q1 2025
-0.59
-0.39
-0.2
0

Details

Expected EPS
N/A
Actual EPS
-0.22270355681999998
Surprise EPS
-0.22
Surprise Percent
+∞%

Description

Allergy Therapeutics (AGY.LSE) has reported earnings of -0.22270355681999998 per share for Q1 2025.

0 Comments

Share your thoughts